💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Five Prime Therapeutics, Inc. (FPRX)
« Back to company indexFPRX Chatter Timeline
Stock Ticker for FPRX
Most Active Tweeters for FPRX
| User | Tweets |
|---|---|
| @YuZhu4 | 4 |
| @Tickeron | 4 |
| @innersigma | 4 |
| @intratio | 3 |
| @anticancervibe | 3 |
Recent Tweets for FPRX
 |
@YuZhu4 RT @hemonctrader: $FPRX Undervalued IMHO. GI ASCO Ph2 data in 1st line combo with FOLFOX for FGFR2b(30%) is impressive. Mono activity. Plan… January 18th 2021, 9:01pm |
 |
@kwhenfinance Five Prime Therapeutics Inc. Shares Close the Day 10.9% Lower - Daily Wrap https://t.co/vdtP0kckw0 $FPRX #stockmarket #kwhenfinance January 17th 2021, 8:01pm |
 |
@hemonctrader $FPRX Undervalued IMHO. GI ASCO Ph2 data in 1st line combo with FOLFOX for FGFR2b(30%) is impressive. Mono activity… https://t.co/GzKBvNt3wS January 17th 2021, 3:01pm |
 |
@anticancervibe @bigpharmaguy @OxAnalyst $FPRX did the same at GI ASCO with p value of 0.07 and it was an oral :) January 17th 2021, 4:01am |
 |
@NotthatkindofDr An interesting note that I missed from $FPRX data: they do appear to have a reliable biomarker in their FGFR2-IHC.… https://t.co/LLJlwWBS6u January 16th 2021, 7:01pm |
|
@kwhenfinance Five Prime Therapeutics Inc. Shares Close the Day 10.9% Lower - Daily Wrap https://t.co/llhSr4po3O $FPRX #stockmarket #kwhenfinance January 16th 2021, 12:01pm |
 |
@Gambiste1 RT @anticancervibe: $FPRX Can anyone explain how the FIGHT trial met statistical significance with a p value > 0.05 ? The primary endpoin… January 16th 2021, 4:01am |
 |
@Alexand76592800 *Another great week! Gains of over 2400% and over 18% returns!! A big thank you to this community.* $PT $FPRX… https://t.co/oWR0VsRy7K January 16th 2021, 3:01am |
|
@anticancervibe $FPRX Can anyone explain how the FIGHT trial met statistical significance with a p value > 0.05 ? The primary end… https://t.co/hFfutYH2Tp January 16th 2021, 2:01am |
 |
@SeekingAlpha $FPRX - Five Prime Therapeutics (FPRX) Presents at ASCO Gastrointestinal Cancer Symposium 2021 - Slideshow.… https://t.co/kDD6my9bhC January 15th 2021, 10:01pm |
 |
@StockTexts $FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/ldtbtJHf7D January 15th 2021, 10:01pm |
 |
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $FPRX FIVE PRIME THERAPEUTICS, INC https://t.co/K1zFw1xqyh January 15th 2021, 10:01pm |
 |
@fintel_io $FPRX / Five Prime Therapeutics files form 8-K - Results of Operations and Financial Condition - 8-K https://t.co/b4OMb36Sf9 January 15th 2021, 10:01pm |
 |
@FlashAlert_me $FPRX [15s. delayed] filed form 8-K on January 15, 17:00:53: Item2.02: Results of Operations & Financial Condition https://t.co/inS2VAbrxo January 15th 2021, 10:01pm |
 |
@goldmask123 RT @_B_I_O_T_E_C_H_: $FPRX FIVE PRIME THERAPEUTICS INC - ALL THREE EFFICACY ENDPOINTS (PFS, OS AND ORR) IN FIGHT PHASE 2 TRIAL MET PRE-SPEC… January 15th 2021, 9:01pm |
 |
@innersigma 03:58:23 PM DREV Automated Exit. Closing my $FPRX position of 1765 shares that was opened today for a 0.45% gain. January 15th 2021, 9:01pm |
 |
@MarketChmln $FPRX stock declines -10.4%. View latest news. https://t.co/zJkmJ1ETVg January 15th 2021, 9:01pm |
 |
@Ezehtim $FPRX bought heavy now January 15th 2021, 4:01pm |
|
@innersigma 11:00:35 AM DREV Automated Entry. Long 1766 shares of $FPRX at 14.16 for a trade that I will be looking to close today. January 15th 2021, 4:01pm |
 |
@MarcJacksonLA $FPRX Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce P… https://t.co/hZSI9KplT6 January 15th 2021, 3:01pm |
|
@StockTexts $FPRX Five Prime Therapeutics, Inc. SEC Filing: Form 8-K https://t.co/9zqEkvm8Tu January 15th 2021, 3:01pm |
|
@EdgarInsider Filing Alert, FORM 8-K [Press/News Current Report] available. $FPRX FIVE PRIME THERAPEUTICS, INC. FIVE PRIME THER… https://t.co/Q4s1fJWn0O January 15th 2021, 3:01pm |
|
@FlashAlert_me $FPRX [15s. delayed] filed form 8-K on January 15, 10:06:39: Item8.01: Other Material Events https://t.co/GrE3874sGZ January 15th 2021, 3:01pm |
 |
@StockPlays $FPRX Five Prime Therapeutics Phase 2 trial met all three efficacy endpoints and demonstrated statistically signifi… https://t.co/XABSs0MhrJ January 15th 2021, 2:01pm |
 |
@Briefingcom $FPRX: Five Prime Therapeutics reports Phase 2 FIGHT trial results presented at ASCO GI that validate importance of… https://t.co/fc5XLw6OTp January 15th 2021, 1:01pm |
 |
@IOInvestors $FPRX +16.5% (reports Phase 2 FIGHT trial results presented at ASCO GI that validate importance of FGFR2b overexpre… https://t.co/Dim3iIyudL January 15th 2021, 1:01pm |
|
@MarketChmln $FPRX gains in premarket trading. See the latest news. https://t.co/coYu1gm2Fb https://t.co/rlFGc3Q8xy January 15th 2021, 1:01pm |
 |
@NewsQuantified $FPRX announced clinical results from the global, randomized, double-blind placebo-controlled Phase 2 FIGHT trial e… https://t.co/BkvQfzE2yN January 15th 2021, 1:01pm |
 |
@StckPro $FPRX NEW ARTICLE : Five Prime's bemarituzumab shows PFS benefit in mid-stage gastric cancer study… https://t.co/vVjwn2gUfa January 15th 2021, 12:01pm |
 |
@MarketCurrents $FPRX - Five Prime's bemarituzumab shows PFS benefit in mid-stage gastric cancer study https://t.co/f6brJc2Rwr January 15th 2021, 12:01pm |
 |
@BankTheTrade $FPRX(15.96) up 3.75 announced clinical results from the global, randomized, double-blind placebo-controlled Phase… https://t.co/2qLXHNGdnl January 15th 2021, 12:01pm |
 |
@TeamofStockTra $FPRX - Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce… https://t.co/z3MGstNGfb January 15th 2021, 12:01pm |
 |
@sbwcws Five Prime says Phase 2 FIGHT trial met all three efficacy endpoints $FPRX January 15th 2021, 12:01pm |
 |
@JanEhses Slides of the full dataset of the FIGHT phase 2 trial now available. $FPRX https://t.co/hqQLWkD2Ew January 15th 2021, 12:01pm |
 |
@_B_I_O_T_E_C_H_ $FPRX FIVE PRIME THERAPEUTICS INC - ALL THREE EFFICACY ENDPOINTS (PFS, OS AND ORR) IN FIGHT PHASE 2 TRIAL MET PRE-S… https://t.co/KEej9dkCKS January 15th 2021, 12:01pm |
 |
@stock_titan $FPRX Phase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression and Reinforce P… https://t.co/SvhRXHYiPx January 15th 2021, 11:01am |
|
@innersigma 03:58:10 PM DREV Automated Exit. Closing my $FPRX position of 1721 shares that was opened today for a 2.99% gain. January 13th 2021, 9:01pm |
 |
@TradeWithAlerts Large Print $FPRX Size: 125679 Price: 15 Time: 1453 Amount: $1,885,185.00 January 13th 2021, 7:01pm |
|
@YuZhu4 RT @Fallenfloweronw: $FPRX has been going down into the ASCO presentation this Friday. Word is that they have nothing new, since the Novemb… January 13th 2021, 7:01pm |
|
@YuZhu4 RT @Santabanta84: @MSollender $FPRX Grade =3 AEs ( 83% on bema vs 74% on pbo), serious AEs in 32% and 36% respectively. Stomatitis highe… January 13th 2021, 7:01pm |
|
@YuZhu4 RT @anticancervibe: @svarre001 What do you think of $FPRX data in ASCO GI ? median PFS of 9.5 mo (bema) vs 7.4 mo (pbo) (hazard ratio [… January 13th 2021, 7:01pm |
|
@NotthatkindofDr Doing a little profit taking today and buying. Trimming around my core $CTMX position, $FPRX hit my 17 stop & broke… https://t.co/wpGDYL9XE0 January 13th 2021, 6:01pm |
|
@anticancervibe @svarre001 What do you think of $FPRX data in ASCO GI ? median PFS of 9.5 mo (bema) vs 7.4 mo (pbo) (hazard rat… https://t.co/a1zU69qtQG January 13th 2021, 6:01pm |
|
@innersigma 01:16:09 PM DREV Automated Entry. Long 1721 shares of $FPRX at 14.53 for a trade that I will be looking to close today. January 13th 2021, 6:01pm |
 |
@SdO7 $FPRX Perfect candidate for a multibillion partnering deal with BP… ACCUMULATE January 13th 2021, 3:01pm |
 |
@Fallenfloweronw $FPRX has been going down into the ASCO presentation this Friday. Word is that they have nothing new, since the November data, to report January 13th 2021, 3:01pm |
 |
@intratio $FPRX https://t.co/Bf3tPh3MwR Five Prime Therapeutics Inc The algorithm estimates this stock s value won t see its… https://t.co/3nz9KCENt4 January 13th 2021, 12:01am |
|
@sbwcws Five Prime to hold a conference call $FPRX January 12th 2021, 4:01pm |
|
@MarcJacksonLA $FPRX $BMY Laryngeal Cancer Survivor Credits Phase 1 Trial For Lifesaving Results https://t.co/rztdLjJON0 January 12th 2021, 1:01pm |
 |
@zbiotech RT @MSollender: $FPRX ASCO GI abstract, more detailed Ph2 bemarituzumab data AE profile: Stomatitis was higher in the bema arm (31.6% vs… January 12th 2021, 4:01am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Make Better Decisions
Finding and Evaluating Generic and Branded Drug Market Entry Opportunities